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activity behaviour change in obese pregnant
women (the UPBEAT trial); assessment of
behavioural change and process evaluation
in a pilot randomised controlled trial
Lucilla Poston1*, Annette L Briley1, Suzanne Barr2, Ruth Bell3, Helen Croker6, Kirstie Coxon1, Holly N Essex5,
Claire Hunt1, Louise Hayes3, Louise M Howard1, Nina Khazaezadeh1, Tarja Kinnunen8, Scott M Nelson7,
Eugene Oteng-Ntim1, Stephen C Robson4, Naveed Sattar7, Paul T Seed1, Jane Wardle6, Thomas AB Sanders2
and Jane Sandall1Abstract
Background: Complex interventions in obese pregnant women should be theoretically based, feasible and shown
to demonstrate anticipated behavioural change prior to inception of large randomised controlled trials (RCTs). The
aim was to determine if a) a complex intervention in obese pregnant women leads to anticipated changes in diet
and physical activity behaviours, and b) to refine the intervention protocol through process evaluation of
intervention fidelity.
Methods: We undertook a pilot RCT of a complex intervention in obese pregnant women, comparing routine
antenatal care with an intervention to reduce dietary glycaemic load and saturated fat intake, and increase physical
activity. Subjects included 183 obese pregnant women (mean BMI 36.3 kg/m2).
Diet was assessed by repeated triple pass 24-hour dietary recall and physical activity by accelerometry and
questionnaire, at 16+0 to 18+6 and at 27+0 to 28+6 weeks’ gestation in women in control and intervention arms.
Attitudes to behaviour change and quality of life were assessed and a process evaluation undertaken. The full RCT
protocol was undertaken to assess feasibility.
Results: Compared to women in the control arm, women in the intervention arm had a significant reduction in
dietary glycaemic load (33 points, 95% CI −47 to −20), (p < 0.001) and saturated fat intake (−1.6% energy, 95% CI
−2.8 to −0. 3) at 28 weeks’ gestation. Objectively measured physical activity did not change. Physical discomfort
and sustained barriers to physical activity were common at 28 weeks’ gestation. Process evaluation identified
barriers to recruitment, group attendance and compliance, leading to modification of intervention delivery.
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Conclusions: This pilot trial of a complex intervention in obese pregnant women suggests greater potential for
change in dietary intake than for change in physical activity, and through process evaluation illustrates the
considerable advantage of performing an exploratory trial of a complex intervention in obese pregnant women
before undertaking a large RCT.
Trial registration: Trial Registration Number: ISRCTN89971375
Keywords: Pregnancy, Obesity, Diet, Physical activity, Complex intervention, EvaluationBackground
Obesity is prevalent in women of reproductive age in both
high and low-to-middle income countries [1]. Pregnant
obese women have a heightened risk of adverse pregnancy
outcomes [2], but at present there is no evidence-based
intervention that can be introduced into clinical practice to
improve pregnancy outcome in obese women. The majority
of attempts to develop interventions have hitherto focused
on limiting gestational weight gain (GWG) according to the
USA Institute of Medicine (IOM) recommendations [3].
Recent meta-analyses of relevant studies in obese women
show modest restriction of GWG without robust evidence
for improved clinical outcome [4,5]. Limitations of
the existing evidence include poor study design, small sam-
ple size, absence of a theoretical basis and, importantly, no
a priori demonstration of the feasibility of the intervention
in regard to changing the specific behaviours targeted [6].
We have developed a theoretically based behavioural group
intervention (diet and physical activity) for obese pregnant
women with the primary aim of improving maternal glu-
cose homeostasis. As maternal insulin resistance is integral
to many complications of obese pregnancy the dietary
intervention focuses on lowering the dietary glycaemic
index (GI), previously shown to improve pregnancy out-
come in women with gestational diabetes (GDM) [7,8]. In-
creased physical activity can also improve metabolic control
and reduce GDM risk in pregnant women [9].
Prior to embarking on a large randomised controlled
trial (RCT) and in accordance with UK Medical Research
Council Guidance for development of a complex interven-
tion [10], we first explored the theoretical basis for an
intervention in obese pregnant women [5,6,11,12], leading
to development of a novel intervention (Phase 1). We now
report on Phase 2, an exploratory trial to determine
whether this intervention achieved the changes in dietary
and physical activity behaviours anticipated, and to under-
take a process evaluation of every aspect of fidelity of the
intervention and the protocol.Subjects
Potentially eligible participants attending clinics for gen-
eral antenatal care were approached by research mid-
wives in four UK study centres in urban settingsproviding a range of models of care. The contributing
hospitals were 1) The Southern General Hospital and
Princess Royal Maternity Hospital (Glasgow), 2) The
Royal Victoria Infirmary (Newcastle), 3) Guy’s and St
Thomas’ NHS Foundation Trust (London) and 4) King’s
College Hospital Foundation Trust (London).Methods
The protocol for the exploratory trial is shown in Figure 1.
Verbal and printed information was provided to poten-
tial participants at a routine antenatal appointment in the
first trimester and women were contacted >24 hrs later to
ascertain willingness to participate. For those declining
participation, consent to record basic demographic data
and BMI were obtained. Those willing to participate were
invited to return for their first study appointment in the
early second trimester (>15+0 weeks to <17+6 weeks’ gesta-
tion). This window of recruitment allowed adequate time
for arrangement of the one to one session with the health
trainer followed by the eight week intervention prog-
ramme prior to the oral glucose tolerance test, carried out
between 27+0 and 28+6 weeks’ gestation. Research mid-
wives received a study-specific manual, attended at least
one training session with the trial manager and continued
feedback and training sessions for the study duration.
Inclusion criteria: BMI ≥30 kg/m2 and singleton preg-
nancy; gestational age >15+0 weeks and <17+6 weeks’
gestation.
Exclusion Criteria: Unable or unwilling to give written
informed consent; gestation <15+0 weeks and >17+6 weeks;
pre-existing diabetes; pre-existing essential hypertension
(treated); pre-existing renal disease; multiple pregnancy;
systemic lupus erythematosus (SLE); antiphospholipid
syndrome; sickle cell disease; thalassemia; celiac disease;
currently prescribed metformin; thyroid disease or current
psychosis.
All data were entered onto a password protected secure
database (MedSciNet Ltd). Randomisation was performed
online. The randomised treatment was allocated automa-
tically, balanced by minimisation for maternal age, centre,
ethnicity, parity and BMI. Data were analysed using Stata
(version 11.2, StataCorp, College Station, Texas). All
women randomised between 29th March 2010 and 13th
Potentially eligible women 
contacted by research midwife
Agrees to take part
First appointment (15+0-17+6 weeks’ 
gestation)
Consent; BMI; eligibility check; demography 
and socioeconomic status; dietary 
assessment; attitudinal assessment 
questionnaire; accelerometer provided.
Second Appointment (1 week later)
Randomisation; dietary assessment; 
accelerometer data downloaded; EPDS, EQ-
5D, RPAQ questionnaires; anthropometry; 
weight; blood sample
Control Arm Standard 
antenatal care Intervention Arm
8 weekly sessions with health 
trainerThird Appointment (27+0-28+6 weeks’ 
gestation)
OGTT; dietary assessment; attitudinal 
assessment, EPDS,EQ-5D 
questionnaires; weight; anthropometry; 
blood sample; accelerometer provided
Declines participation
confirm permission to 
collect outcome data
Fourth Appointment (1 week later)
Dietary assessment; accelerometer data 
downloaded; RPAQ questionnaire; 
weight
Fifth Appointment (34+0-35+6)
As 3rd appointment (no OGTT)
Sixth Appointment (1 week 
later) As 4th appointment
Maternal and neonatal outcome data
Figure 1 Study protocol. Abbreviations: BMI, Body Mass Index; EQ-5D, EuroQuol Quality of Life Questionnaire; EPDS, Edinburgh postnatal
depression score questionnaire; OGTT, oral glucose tolerance test; RPAQ, Recent Physical Activity Questionnaire.
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national indices of deprivation: the Index of Multiple
Deprivation (IMD) for English addresses, or the Scottish
Index of Multiple Deprivation (SIMD) for addresses in
Scotland [13,14].
Control arm; standard care
Following randomisation, women in the control arm
returned for data collection appointments with the study
midwife at 27+0 -28+6 and 34+0-36+6 weeks’, where pos-
sible coinciding with routine antenatal visits.
Intervention arm
Following randomisation, participants attended a one-
to-one appointment with the health trainer (HT) andwere invited to weekly group sessions for 8 consecutive
weeks from approximately 19 weeks’ gestation.
All women attended routine antenatal care appoint-
ments and received advice regarding diet and physical
activity (PA) in accordance with local policies, which
draw on UK NICE guidelines [15].
Sample size
The primary outcome was change in dietary and PA be-
haviours at 28 weeks’ gestation (coinciding with the pri-
mary maternal outcome for the main RCT, GDM at
28 weeks’). No prior investigation in obese pregnant
women was available to inform power at the planning
stage. The sample size of 183 was determined by the
predefined duration of Phase 2, the exploratory phase.
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for primary endpoints of the subsequent RCT, by provid-
ing estimates of the variance to within approximately 7%
of the true value.Ethics
Research Ethics Committee approval was obtained in all
participating centres, UK Integrated Research Applica-
tion System; reference 09/H0802/5 (South East London
Research Ethics Committee).The intervention
The intervention was informed by psychological models of
health behaviour including control theory [16] and social
cognitive theory [17]. Although no clear patterns between
intervention characteristics and outcomes have been seen
to date in lifestyle interventions in pregnancy, and few
studies have described their theoretical basis [5,6]. Self-
regulation techniques, drawn from control theory, suggest
that behaviour change is facilitated by feedback about per-
formance compared to pre-specified goals [16,18]. This
approach was utilised in this study by setting ‘SMART’
(Specific, Measurable, Achievable, Relevant, and Time
Specific) diet and activity goals, with behaviours recorded
in a log book. Identification of benefits and overcoming
barriers to behaviour change, and increasing self-efficacy
were also included, and social support facilitated through
the group format [17]. Following initial feedback from
HTs regarding difficulties encountered by some women in
attending sessions, for those women unable to attend, the
session content was delivered by phone or email.Dietary advice
Pre-specified dietary outcomes were a change in GI, gly-
caemic load (GL) (an indicator of carbohydrate quality (GI)
and quantity consumed), and energy intake from saturated
fatty acids (SFA). The focus of the dietary advice to the
intervention group was therefore on increased consump-
tion of foods with a low dietary GI, including replacement
of sugar sweetened beverages with low GI alternatives. Re-
duction in saturated fats and replacement with monoun-
saturated and polyunsaturated fat was also recommended.
Exchange of foods was emphasised e.g. a high GI food for
a low GI food, rather than limiting energy intake.Physical activity advice
Women in the intervention arm were encouraged to in-
crease daily PA incrementally, setting goals of incremen-
tal step counts (monitored by pedometer) and
maintaining the achieved PA level after the intervention
period. Recommendations included an emphasis on
walking at a moderate intensity level [19].Intervention delivery
The intervention was delivered by health trainers (HTs).
In the UK, HTs do not have pre-specified health profes-
sional qualifications, but relevant experience (http://
informationstrategy.dh.gov.uk/health-trainer-workforce).
All HTs received a comprehensive treatment manual, pre-
study training (and within-study supervision) in behaviour
modification and conducting group sessions (organised by
Weight Concern; Registered Charity 1059686). The ses-
sions were held in a hospital setting in all but one centre,
where women attended a community children’s centre. At
the initial one-to-one appointment women were provided
with a participant handbook, reflecting the rationale and
content of the HT sessions, a pedometer (Yamax SW-200
Digiwalker), a log book for weekly SMART goals and re-
lated behaviours (steps, PA and diet) and a DVD of a spe-
cially devised pregnancy exercise regime. Potential benefits
of attending group sessions were discussed. Each group
session delivered a different element of the dietary and PA
intervention. Additional file 1: Table S1. Goals from the
previous week were reviewed and goals set for the follow-
ing week. Discussion included barriers to behavioural
change and ways these might be overcome.
The following information was obtained from all par-
ticipants (at visits indicated in Figure 1).Attitudinal assessment questionnaire
The attitudinal assessment included questions relating
to perceived benefits and barriers and confidence to
carry out the dietary and PA behaviours [20,21]. The tar-
get behaviours were to consume lower GI carbohydrates,
to reduce saturated fat intake and to increase PA.Health status and mental health
The EuroQol quality of life (EQ- 5D) questionnaire [22] was
used to assess health status, and the Edinburgh Post Natal
Depression Score (EPDS) to assess mental health [23].Dietary assessment
Repeated, triple pass 24 hr recall data obtained at baseline
(randomisation) and 28 weeks’ gestation were evaluated
twice, one week apart in both the intervention and control
group. The 24 hr dietary recall is a standard retrospective,
interviewer led dietary assessment methodology used to
capture information on all food and drinks consumed in
the preceding 24 hrs. This is carried out in three stages
(the triple pass), which includes 1) recording a ‘quick’ list
of foods eaten or drunk, 2) collecting more detailed infor-
mation of these foods and 3) reviewing all items once
more in order to clarify any ambiguities or omissions. A
short food frequency questionnaire (FFQ), for later valid-
ation, was also completed.
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At the first and third appointments participants were
asked to wear an Actigraph™ accelerometer (Florida,
USA) (either GT1M or GT3X set to uniaxial mode) for
seven consecutive days, removing it for washing, bath-
ing, swimming and at night. PA was also assessed by
questionnaire (Recent Physical Activity Questionnaire
(RPAQ).
Process evaluation
A process evaluation, following Steckler and Linnan’s
[24] framework was undertaken. This explored 1) Con-
text (environmental, socio-economic or political factors),
2) Reach (the proportion of the intended target audience
that participates, and which subgroups, if any, do not
participate), 3) Dose delivered and dose received (the
proportion of intended intervention received) 4) Fidelity
(if each component of the complex intervention was
provided as intended) and 5) Acceptability (if the inter-
vention materials and advice were well received by pro-
viders and participants).
Qualitative semi-structured interviews were conduc-
ted, to capture women’s experiences and perceptions of
the trial and intervention. Women were recruited from
each of the participating study sites using a maximum
diversity sampling approach, following an informed con-
sent procedure. Interviews took place between November
2010 and February 2011, and were either face-to-face
(n = 17), mostly in hospital settings, or by phone (n = 4).
Control (n = 12) and intervention (n = 9) interviewees
were asked about their involvement in the research and
their experiences of the trial appointments, measure-
ments, blood tests and accelerometry recordings.
Women in the intervention arm were additionally
asked about their perceptions of the different compo-
nents of the intervention, and how these impacted
upon their lives. The interviews were conducted by one
researcher and took place during pregnancy after the
intervention had been provided. In addition, health
trainers completed audio diaries (130 recordings) in
which they reflected on the fidelity and feasibility of the
intervention delivery. Attendance at sessions was
recorded on the study database.
Clinical outcome data
Maternal primary outcome for the subsequent RCT
(diagnosis of GDM)
A blood sample for fasting glucose and insulin was taken
after an overnight fast. For the OGTT, following a glu-
cose load (410 ml of lucozade or 75 g glucose in water),
1 hr and 2 hr samples were taken for glucose measure-
ment. Diagnosis of GDM was confirmed by fasting glu-
cose ≥ 5.1 mmol/L and/or 1 hr glucose ≥10 mmol/L;
2 hr glucose ≥8.5 mmol/L according to the InternationalAssociation of the Diabetes and Pregnancy Study
Groups (IADPSG) guidelines [25]. Following GDM diag-
nosis, women were referred for routine GDM care
according to local criteria.
Neonatal primary outcome for the subsequent RCT (large
for gestational age delivery (LGA) defined as >90th
customised birthweight centile)
Customised birthweight centiles were calculated correcting
for gestational age, maternal ethnicity, weight and height in
early pregnancy, parity and infant sex [26]. Weight adjust-
ment for women with BMI ≥30 kg/m2 is based on a no-
tional weight corresponding to a BMI of 29.9 kg/m2.
Outcome data also recorded (not reported)
These included maternal outcomes: diagnosis of GDM
and pre-eclampsia, gestational weight gain, mode of de-
livery, blood loss at delivery, inpatient nights, detailed
clinical and family history, health in current pregnancy,
early pregnancy data (ultrasound scan, nuchal screening),
blood pressure, routine blood results; neonatal outcomes:
gestational age at delivery, birthweight, anthropometry, in-
patient nights. Maternal urine and cord blood samples
were also provided.
Data handling and statistical analysis
Health quality and attitudinal assessment questionnaires
The generic EQ-5D health-related quality of life instru-
ment [22] is reported as the proportion of women with
problems on individual dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression).
It is given as a summary index score calculated from pref-
erence values of different combinations of the dimensions
elicited using the time trade-off method in a sample repre-
sentative of non-institutionalized adults in England,
Scotland and Wales (range −0.59 to 100 where −0.59 is se-
vere problems on all dimensions) [27,28]; and also the vis-
ual analogue scale (VAS) of health-related quality of life
(range 0 to 100 where 0 is worst imaginable health state).
The change between baseline and 28 weeks’ gestation in
the percentage of women with any problem was assessed
using McNemar’s test of changes. Attitudes to target be-
haviours (attitudinal assessment questionnaire) are based
on the average of multiple responses on 5-point scales (3
responses for diet, 13 for PA) with 5 indicating the greatest
perceived barrier, perceived benefit, or level of confidence.
Assessment of deprivation
These scales for estimation of deprivation in England
and Scotland [13,14] use different reference populations
to determine the actual indices of deprivation, and are
therefore not directly comparable. For the purposes of
this study, the most deprived quintile is presented
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to the remainder of the population (quintiles 1–4).
Dietary analysis
Quality of dietary data was checked within one week of
entry. Dietary coding utilised McCance and Widdowson
“Composition of Foods” (6th edition) food codes and nu-
trient composition was evaluated using WISP 3.0
(Tinuviel Software) for GI and GL values [29]. Estimates
using previously published methodology were made
when GI values were not available [30]. 24 hr recall data
obtained at baseline (randomisation) and at 28 weeks’
gestation was evaluated twice, one week apart, and data
were averaged. The validity of the short FFQ was
assessed against the dietary recall data. Pre-specified
dietary outcomes were a change in GI, GL and energy
intake from SFA. Total energy intake, the proportion of
energy derived from macronutrients were assessed.
Actigraph analysis
An epoch length (time sampling interval) of 15 seconds
was specified. Data were processed using the MAHUFFE
Software package [31]. Sedentary behaviour was defined as
<100 counts per minute (cpm), light activity as 100–
1951 cpm, moderate intensity activity as 1952–5725 cpm
and vigorous activity as > 5725 cpm [32]. As time spent in
vigorous activity was very low, minutes of moderate and
vigorous physical activity (MVPA) were combined. Runs
of zero counts lasting >60 minutes were excluded, as these
indicated monitor removal. A valid recording was defined
as a day in which >500 minutes of monitored on-time
were recorded in 24 hrs [33]. Data from participants re-
cording ≥3 days of valid accelerometry data were included
in the analysis. The specified PA outcome was an increase
in minutes per day of MVPA recorded by accelerometry.
Recent physical activity questionnaire (RPAQ)
The RPAQ was modified for the assessment of PA in the
preceding seven days. Estimates of minutes per day
spent in light, moderate and vigorous activity in each of
the domains were calculated. Sedentary activities were
defined as those with a metabolic equivalent (MET) of
<1.5. Light activities were those of 1.5 to 3 METs. Mod-
erate activities were those of 3 to 6 METs. Vigorous ac-
tivities were those of 6 METs or greater [34] MVPA
were combined to give one summary variable.
Process evaluation
Interviews were recorded and transcribed verbatim. Tran-
scripts were anonymised and a unique identifier (ID num-
ber) was used to maintain confidentiality. Data were
imported into a qualitative software analysis package
(NVivo 8), and subject to comparative thematic analysis
[35]. To enhance study validity and reliability, themesarising from the research were discussed, the data
supporting these was reviewed by co-researchers, and data
were compared between sites and with existing literature.
By these methods, assumptions were tested and observa-
tions of differences and their relationship to the theoretical
models underpinning the study were explored.
Statistical analysis
Analyses followed the intention-to-treat principle. Fol-
lowing CONSORT guidelines, risk ratios and risk differ-
ences were estimated by binary regression for Yes/No
outcomes. Where measures were repeated at baseline
and 28 weeks’ gestation, results [mean (SD) n (%)] are
presented separately at each time point. Randomised
comparisons at 28 weeks’ were made using linear regres-
sion with robust standard errors, adjusting for the base-
line value. For PA data, dummy variables were used
when the baseline values were missing. Correlations be-
tween PA as assessed objectively (accelerometry) and
when self-reported (RPAQ) were explored.
Results
Figure 2 provides a flow chart of participants through
the study.
Participants
Mean first visit BMI was 36.3 kg/m2. More than half the
women were White and the remainder from Black (38%)
and Minority Ethnic communities. More than half (56%)
already had at least one child. More than half of those
from centres in England and over 40% in Scotland came
from regions in the highest quintile of social deprivation
(Table 1).
Diet
Table 2 shows the dietary intakes at baseline and at
28 weeks of gestation. There were no differences between
groups in energy intakes, GI, GL, or other macronutrient at
baseline. However, following the intervention, at 28 weeks’
gestation, total energy intake, dietary GL, GL (%E), satu-
rated fat (%E) and total fat (%E), were significantly lower
and fibre intake measured as non-starch polysaccharides
was greater in the intervention group than in the control
arm. The proportion of energy derived from protein was
higher in the intervention group but absolute protein intake
did not differ. There was a difference of 7 GI points be-
tween the intervention and control group which achieved
borderline statistical significance (P = 0.054).
Physical activity
There were no differences between the intervention and
control arms in objectively measured PA variables at
baseline or at 28 weeks’ gestation, after adjustment for
baseline activity. Self-reported moderate to vigorous PA
Allocated to intervention arm (n=94)
Randomised (n=183)
Assessed for eligibility (n=909):
Singleton pregnancy 15+0 to 17+6 weeks gestation and BMI ≥ 30kg/m2
Women with certain pre-existing conditions excluded
Excluded (n=726):
Did not meet inclusion criteria (n=243)
Declined to participate (n=473)
Miscarriage/TOP after consent (n=10)
Allocated to control arm (n=89)
Lost to follow-up:
Women: n=15
Neonates: n= 9
Discontinued intervention: 4
Preterm delivery: 0
Withdrew: 4
Analysed:
Women: n=79
Neonates: n= 85
Excluded from analysis:0 
Lost to follow-up:
Women: n=14
Neonates:  n=5
Analysed (primary endpoint):
Women: n=75
Neonates: n=84
Excluded from analysis: 0 
Figure 2 Consort Diagram. Flow chart of participants through study.
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intervention group (mean difference 34 minutes/day;
95% CI 9 to 59 min/day), but this was not supported by
the objective data. Women in the intervention group
self-reported walking for leisure for 14 min/day more
than those in the control group at 28 weeks’ gestation
(95% CI 5 to 23 min, p = 0.003). Agreement between the
RPAQ questionnaire and accelerometry was very poor, for
example, correlations between MVPA in the two formats
at baseline were r = 0.275 (95% CI: 0.107 to 0.428) and at
28 weeks, r = −0.069 (95% CI: -0.296 to 0.165) Table 3.
Attitudinal assessment of target behaviours
Benefits, barriers and confidence in making the target
physical activity and dietary changes were unchanged in
either the control and intervention groups from baseline
to 28 weeks gestation Table 4.
Health Status and Mental Health EPDS EQ-5D
There was no influence of the intervention on the num-
bers of women reporting problems in each of the EQ-5D
domains, but as a group, obese women experienced a
significant increase in problems with mobility, self care,
usual activities and pain and discomfort from baseline to28 weeks’ gestation. There was a 10% prevalence of
probable depression at baseline and 13% at 28 weeks (i.e.
EPDS score>12) with no significant effect of the inter-
vention on anxiety and depression at 28 weeks Table 4.
Process evaluation
Context
This study coincided with publication of new reports
and guidance for obesity in pregnancy with associated
media coverage [15,36]. Most control group interviewees
demonstrated awareness and reported taking steps to
improve their diet or fitness. Additional file 1: Table S2.
Reach
Those approached who were eligible for recruitment but
declined to participate (n = 473) were of mean age
29.9 years; mean BMI 35.39 kg/m2; ethnicity, 59.7% White,
32.8% Black and 43.0% were in the lowest quintile for Index
of deprivation indicating the most severe deprivation. Cha-
racteristics of participants providing semi-structured inter-
views (n = 21) are shown in Additional file 1: Table S3. This
demographic profile was similar to study participants
(Table 1). Overall, 29/183 (15.8%) women were lost to fol-
low up Figure 2.
Table 1 Description of subjects at baseline (16+0-18+6 weeks
gestation) by randomised treatment
Control Intervention
n = 89 n = 94
Age (years) 1 30.7 (4.9) 30.4 (5.7)
Age categories
18-25 16 (18%) 22 (23%)
26-30 25 (28%) 27 (29%)
31-40 46 (52%) 42 (45%)
41 plus 2 (2%) 3 (3%)
Anthropometry
Height (m) 1.64 (0.07) 1.64 (0.07)
Weight (kg) 96.8 (16.2) 97.8 (12.7)
BMI (kg/m2) 36.1 (4.8) 36.5 (4.7)
Ethnicity 1
White 51 (57%) 52 (55%)
Black 32 (36%) 38 (40%)
Asian 1 (1%) 2 (2%)
Other 5 (6%) 2 (2%)
Parity 1
0 38 (43%) 42 (45%)
1 36 (40%) 29 (31%)
2 or more 15 (17%) 23 (24%)
Cigarette smoking
Never 61 (68%) 63 (67%)
Ex-smoker 22 (25%) 25 (27%)
Current 6 (7%) 6 (6%)
Number of cigarettes
0 83 (93%) 83 (88%)
1-5 per day 3 (3%) 3 (3%)
11-20 per day 1 (1%) 6 (6%)
6-10 per day 2 (2%) 2 (2%)
Index of multiple deprivation 2
England n = 76 n = 79
Mean (SD) 34 (12) 36 (14)
Quintiles
1-4 (less deprived) 35 (46%) 29 (37%)
5 (most deprived) 41 (54%) 50 (63%)
Scotland n = 12 n = 14
Mean (SD) 28 (11) 30 (20)
Quintiles
1-4 (less deprived) 7 (58%) 8 (57%)
5 (most deprived) 5 (42%) 6 (43%)
Living arrangements
Single 35 (39%) 50 (53%)
With partner 66 (74%) 69 (73%)
With parent(s) 7 (8%) 13 (14%)
Table 1 Description of subjects at baseline (16+0-18+6 weeks
gestation) by randomised treatment (Continued)
Without partner or parents 17 (19%) 17 (18%)
Accommodation
Owned 27 (30%) 21 (22%)
Rented (private) 26 (29%) 27 (29%)
Rented (council) 36 (40%) 46 (49%)
Results shown are mean (SD) or n (%).
1 The randomised treatment allocation is balanced by minimization on
maternal age, centre, ethnicity, and parity.
2 The index of multiple deprivation is calculated for the region of residence
(Lower super output area in England, data region in Scotland) [13,14].
Different methods and reference populations are used in England and
Scotland, and the indices are not directly comparable.
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Of the 94 women randomised to the intervention, 82
(88%) attended at least one group session, and 60 (64%)
attended 4 or more. A total of 42 women (45%) received
material from all eight sessions, 6 by full attendance
(6%) and the remainder when partly/wholly covered by
subsequent phone contact. For all women, 6.1 (SD 2.6)
sessions were attended or partly/wholly covered.
Fidelity
The intervention package (8 HT group sessions) was
provided with good consistency at each study site. Goals
were set at all group sessions, of which 88% were consid-
ered SMART by HTs according to their diaries. The
maximum group size was 5 (mean 2).
Acceptability
Women in both arms of the trial found the research
processes acceptable, and felt supported by the study
midwives. Women in the intervention group were
generally willing, in principle, to attend the eight
health trainer sessions, and most women who attended
valued the group approach, citing opportunities to
raise questions and discuss each other’s experiences.
Some were surprised at the extent of the intervention,
having anticipated a less intensive, more advice-based
approach.
Consistency of attendance at the HT sessions varied
for different reasons including work commitments,
school pick-up times, or feeling too unwell or tired.
Occasionally initial involvement waned when groups
proved smaller than anticipated, although the HT in-
put by phone or email was considered valuable.
Some women found the information contained in the
handbook new, whilst for others it was too basic. The
pedometers and step goals were generally well received.
Setting and reflecting on weekly goals was motivational
for most, but could also invoke feelings of guilt, or a
sense of being observed and judged. Women reported
having watched the DVD, but few used it regularly.
Table 2 Dietary outcomes
Control Intervention Difference(95% CI) P value
n: baseline, 28 weeks’ n = 89, 69 n = 94, 71
Total Energy (MJ/d) Baseline 7.53 (2.21) 7.26 (2.29)
28 weeks 7.71 (2.30) 6.75 (2.57) −0.94 (−1.72 to −0.18) 0.016
Dietary GI (%) Baseline 58 (6) 58 (5)
28 weeks 60 (26) 53 (13) −7 (−15 to 0) 0.054
Dietary GL (g/d) Baseline 133 (48) 129 (41)
28 weeks 146 (55) 111 (39) −33 (−47 to −20) <0.001
GL (%E) Baseline 27.7 (5.3) 28.5 (5.9)
28 weeks 31.3 (13.3) 26.6 (8.0) −4.8 (−8.5 to −1.0) 0.013
Carbohydrate (%E) Baseline 48.0 (8.4) 48.9 (9.6)
28 weeks 48.2 (8.0) 50.0 (8.2) 1.7 (−1.0 to 4.4) 0.207
Protein (%E) Baseline 15.5 (3.6) 16.0 (4.2)
28 weeks 15.5 (3.2) 17.1 (4.9) 1.5 ( 0.1 to 2.8) 0.034
Protein (g) Baseline 69.3(25.3) 68.5 (26.1)
28 weeks 70.6 (24.0) 66.5 (23.5) −4.8 (−12.3 to 2.6) 0.204
Total fat (%E) Baseline 36.0 (8.2) 34.9 (9.3)
28 weeks 35.9 (7.7) 32.5 (7.4) −3.2 (−5.6 to −0.8) 0.010
SFA (%E) Baseline 12.7 (3.9) 12.0 (4.3)
28 weeks 12.9 (3.9) 11.1 (3.8) −1.6 (−2.8 to −0.3) 0.015
MUFA (%E) Baseline 12.1 (4.1) 11.4 (4.0)
28 weeks 11.6 (4.0) 10.4 (3.2) −1.0 (−2.2 to 0.2) 0.088
PUFA (%E) Baseline 6.4 (3.0) 6.0 (3.1)
28 weeks 5.9 (2.8) 6.0 (2.7) 0.13 (−0.8 to 1.1) 0.774
P:S ratio Baseline 0.56 (0.31) 0.56 (0.40)
28 weeks 0.51 (0.35) 0.64 (0.52) 0.13 (−0.01 to 0.28) 0.075
NSP (g) Baseline 11.2 (4.6) 10.4 (4.6)
28 weeks 10.5 (4.2) 12.0 (6.0) 1.77 ( 0.08 to 3.47) 0.040
Abbreviations: GI glycaemic index, GL glycaemic load, MUFA monounsaturated fatty acid, NSP non-starch polysaccharide, P:S ratio polyunsaturated fatty acid,
saturated fatty acid ratio; PUFA polyunsaturated fatty acid, SFA saturated fatty acids,%E: percentage energy.
For each dietary variable, results are presented in two lines: at trial entry (Baseline; 16+0-18+6 weeks’ gestation) and after randomised treatment, with comparisons
and p-values only for the randomised comparison. Comparisons are adjusted for baseline levels throughout.
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any changes as a result of the intervention, most
reported some degree of change, especially in relation
to dietary intake. Reported changes in PA were more
limited, particularly due to pelvic pain or tiredness as
pregnancy progressed. Women often reported aspirations to
increase exercise postnatally. See Additional file 1: Table S3
and S4 for extracts of interviews.Maternal and neonatal outcomes
The primary maternal and neonatal outcomes for the sub-
sequent RCT are shown in Table 5. There were no signifi-
cant differences in GDM or LGA (≥90th customised
centile) between control and intervention arms. There wasalso no significant difference in gestational weight gain be-
tween control and intervention arms (secondary outcome).
The overall incidence of GDM, the primary outcome of
the subsequent RCT (not powered for), according to re-
cent International Association of the Diabetes and Preg-
nancy Study Groups (IADPSG) criteria [25] was 30%,
enabling calculation of the subsequent RCT sample size
(1546 women) for the RCT, powered for a 25% reduction.
Since 38% of potentially eligible women took part in the
pilot study, to achieve this sample size in the main RCT,
approximately 4100 would need to be approached.
Discussion
This study describes a pragmatic and rigorously evalu-
ated pilot study of a complex intervention for diet and
Table 3 Physical activity as measured by accelerometer and RPAQ questionnaire
Control Intervention Treatment effect
By Accelerometer
n: baseline, 28 weeks
n = 72, 39 n = 68, 36
Sedentary Baseline 1172 (95) 1165 (91)
28 weeks 1175 (86) 1197 (77) 21 (−13 to 55)
Active Baseline 217 (65) 225 (58)
28 weeks 209 (82) 194 (68) −11 (−42 to 19)
Light Baseline 178 (54) 184 (50)
28 weeks 175 (81) 161 (61) −9 (−38 to 19)
MVPA Baseline 40 (20) 42 (20)
28 weeks 34 (18) 33 (15) −2 (−9 to 5)
By RPAQ Questionnaire
n: baseline, 28 weeks
n = 80, 54 n = 79, 56
Sedentary Baseline 1007(207) 1009 (187)
28 weeks 1068(177) 1020 (226) −50 (−115 to 16)
Active Baseline 408 (189) 415 (180)
28 weeks 367 (175 410 (219) 45 (−16 to 106)
Light Baseline 354 (180) 356 (164)
28 weeks 333 (165) 340 (204) 11 (−46 to 68)
MVPA Baseline 54 (87) 60 (99)
28 weeks 34 (52) 70 (78) 34 (9 to 59)
Abbreviations: MVPA, Moderate and/or vigorous physical activity; RPAQ, Recent Physical Activity Questionnaire.
Results are measured in minutes/day presented as mean (SD). Treatment effects are mean differences (95% confidence intervals), adjusted for baseline activity;
with dummy variables where baseline levels missing (2 accelerometer, 3 RPAQ).
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The intervention was associated with a significant
change in dietary behaviour. Process evaluation showed
overall acceptability of the protocol but led to several
refinements to improve acceptability and fidelity.
In any lifestyle intervention of diet and physical ac-
tivity, it is important that the pilot study design in-
cludes methods to assess the potential of the
intervention to change these behaviours in the antici-
pated direction of effect. Few assessments of dietary
intake in similar investigations of overweight or obese
women have been attempted [37-39]. We used a 24 hr
recall method to assess dietary intake and while this
may lead to under-reporting of energy intakes, the
reported values are not dissimilar to those of non-
pregnant women in general UK population [40]. The
objectives of the dietary intervention, to bring about
reductions in GL and the proportion of energy derived
from saturated fatty acids, were both achieved. This
suggests that obese pregnant women are amenable to
changing their diet in response to an intervention
based on established theory, and that dietary advice,
frequently delivered by health professionals, is likely to
be successful in achieving dietary change in obese
pregnant women, as previously implied [38]. Thereduction in dietary GL achieved was similar (33% v
45%) to that reported in obese type 2 diabetic non-
pregnant subjects in which improved glycaemic control
was achieved [41]. Recently a similar intervention in
759 pregnant women, showed a lower change in GL
(13%), which was associated with a reduction in gesta-
tional weight gain in women who had previously deli-
vered a large for gestational age infant [42].
The reduction in energy intake observed is consistent
with other studies that have restricted the intake of fat
from meat and dairy products which have not been re-
placed by other sources of food energy [43]. The reduced
GL may also have contributed through effects on satiety
[44]. To our knowledge this is the first study demon-
strating that anticipated changes in diet occur following
delivery of an intervention to lower GL and saturated fat
in obese pregnant women without GDM. Importantly
this occurred despite the focus being on reducing GL by
lowering the intake of added sugars as well as advocating
foods with a lower GI. Focusing on GI tends to modify
the GL from starch whereas the GI from sugar sweet-
ened beverages is less amenable to change. Conse-
quently, dietary advice to decrease the intake of added
sugar, particularly as sugar-sweetened beverages, is likely
to have had an important impact on GL.
Table 4 Attitudes to target behaviours, quality of life and mental health assessment
Attitudes to target behaviours Control Intervention Treatment effect
Barriers
Diet Baseline 2.49 (0.58) 2.37 (0.61)
28 weeks 2.45 (0.58) 2.14 (0.68) −0.18 (−0.35 to 0.00)
Physical activity Baseline 2.64 (0.55) 2.48 (0.63)
28 weeks 2.47 (0.50) 2.20 (0.61) −0.20 (−0.37 to −0.03)
Perceived benefits
Diet Baseline 3.75 (0.72) 3.80 (0.64)
28 weeks 3.79 (0.67) 3.97 (0.80) 0.13 (−0.10 to 0.36)
Physical activity Baseline 3.94 (0.70) 4.04 (0.54)
28 weeks 3.84 (0.60) 4.06 (0.69) 0.17 (−0.04 to 0.38)
Confidence
Diet Baseline 3.78 (0.75) 3.84 (0.64)
28 weeks 3.71 (0.72) 3.85 (0.81) 0.11 (−0.15 to 0.37)
Physical activity Baseline 3.76 (0.88) 3.92 (0.81)
28 weeks 3.77 (0.88) 3.81 (1.06) −0.05 (−0.40 to 0.30)
Quality of life (EQ-5D) Control Intervention Treatment effect
n: baseline, 28 weeks n = 87, 75 n = 94, 80
Numbers reporting problems
Mobility Baseline 10 (11%) 11 (12%)
28 weeks 21 (28%) 25 (31%) 4% (−10 to 18)
Change (all women) 19% (11 to 27)
Self-care Baseline 1 (1%) 0 (0%)
28 weeks 3 (4%) 3 (4%) −0.3% (−6 to 6)
Change (all women) 4% (0 to 8)
Usual activities Baseline 16 (18%) 13 (14%)
28 weeks 26 (34%) 26 (33%) −1% (−15 to 12)
Change (all women) 16% ( 8 to 24)
Pain & discomfort Baseline 38 (43%) 34 (36 %)
28 weeks 45 (60%) 54 (67%) 10% (−1 to 22)
Change (all women) 25% (17 to 34)
Anxiety & depression Baseline 22 (25%) 20 (21%)
28 weeks 11 (15%) 17 (21%) 5% (−4 to 15)
Change (all women) −6% (−14 to 1)
TTO score Baseline 0.85 (0.18) 0.88 (0.14)
28 weeks 0.79 (0.24) 0.79 (0.16) −0.03 (−0.07 to 0.02)
Change (all women) −0.08 (−0.10 to −0.06)
VAS (0 to 100) Baseline 76 (20) 76 (21)
28 weeks 75 (21) 78 (21) 4 (−3 to 10)
Change (all women) −2 (−6 to 2)
EPDS
Total Baseline 7.1 (4.6) 7.4 (4.5)
28 weeks 6.9 (4.2) 7.1 (5.2) 0.1 (−1.1 to 1.3)
Total Score > 9 Baseline 25 (29%) 28 (30%)
28 weeks 17 (23%) 21 (26%) 1% (−9 to 11)
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Table 4 Attitudes to target behaviours, quality of life and mental health assessment (Continued)
Total score > 12 Baseline 9 (10%) 10 (11%)
28 weeks 6 (8%) 14 (18%) 7% (−1% to 16)
Attitude to target behaviours are based on the average of multiple responses on 5-point scales, with 5 indicating the greatest barrier, perceived benefit, or level
of confidence, and 1 the least.
Abbreviations: EQ-5D EuroQol 5 dimensional quality of life scale, TTO Time Trade Off health state ratings calculated from standard values elicited using the time
trade-off method. VAS visual analogue scale, EPDS Edinburgh Postnatal Depression Score. Summaries are n (%) or mean (SD) as appropriate. For the EuroQoL
subscales, the overall change over time is estimated as a risk difference, by McNemar’s test of changes. Elsewhere, differences are calculated by linear or binomal
regression as appropriate, adjusting for baseline values.
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diet of obese pregnant women. The macronutrient pro-
file at randomisation was similar to that of women in
the general population, with fibre (non-starch polysac-
charide) intake below, and total sugars and saturated fat
above recommended UK guidelines [45]. The overall en-
ergy intake and macronutrient profile accords with one
previous report in obese pregnancy [38]. Because of the
time required to rigorously assess diet using the 24 hr re-
call method which, according to the process evaluation is
likely to have influenced recruitment and compliance, a
short food frequency questionnaire (5–10 minutes) was
evaluated for use in the subsequent RCT.
The few studies that have attempted to measure
changes in PA in intervention trials in pregnancy have
generally relied on self-report, and results have been
equivocal [38,46-49]. Accelerometry, the standard
method of objective assessment used previously in ob-
servational studies in pregnancy [48], has, to our know-
ledge, only been employed in one relevant RCT, the
FitFor2 study, a supervised exercise intervention in 121
overweight and obese women [50]. Consistent with
Fitfor2, we found no effect of the intervention on PA
using the Actigraph accelerometer, concurring with the
reported absence of change in barriers to PA. The failure
of accelerometry to mirror the increase in self-reported
walking in the intervention group could reflect insuffi-
cient intensity of this activity, but also reporting bias
[51] which is common in the reporting of low intensity
activities, such as those frequently undertaken by preg-
nant women [52].Table 5 Maternal and neonatal primary outcomes
Control Intervention
Maternal n = 75 n = 79
GDM 24 (32%) 22 (28%)
Neonatal n = 84 n = 86
LGA 7 (8%) 7 (8%)
>4 Kg 16 (19%) 13 (15%)
Abbreviations: GDM Gestational Diabetes Mellitus by IADPSG criteria, LGA Large for
Customized centiles are adjusted for maternal age, height, weight, ethnic group, ge
(all women in study) is based on a notional weight corresponding to a BMI of 29.9
Continuous variables are given as mean (SD) with Mean Difference & 950025 CI. BinAs reported elsewhere, compliance with accelerometry
in pregnancy was an issue [53,54]. Nonetheless, 60% of
obese pregnant women providing baseline accelerometry
data met the current guidelines for PA in pregnancy (i.e.
> 30 minutes of MVPA per day). A similar level of acti-
vity has been observed in pregnant women (all BMIs)
[54] and overweight and obese non-pregnant adults [55],
but not previously amongst obese pregnant women.
Levels of PA were similar to those we found previously
among overweight and obese women [53], but substan-
tially higher than those reported for non-pregnant
women in the UK [56]. There is no consensus on change
of MVPA over pregnancy [53,57-59]. In this study of
obese women both groups reduced the level of object-
ively measured MVPA as pregnancy progressed.
This assessment has highlighted a critical need to
evaluate PA behaviour objectively. We may otherwise
have erroneously concluded in the following RCT that
increased PA does not affect clinically relevant out-
comes. Despite showing no increase in PA, we have not
recommended that the RCT focuses on diet only [4], but
rather that women continue to be encouraged to adhere
to PA recommended in clinical guidelines.
Although there were no changes in attitudinal out-
comes, women were generally positive about the
recommended dietary and physical activity behaviours
despite perceived barriers to change. Attitudinal data re-
lating to diet were comparable to a population sample of
pregnant women [12]. The intervention did not achieve
any reduction in perceived barriers, but despite this, im-
portant dietary changes were achieved which may inferComparison Treatment effect P value
(95% CI)
Risk difference −4% (−19 to 13) 0.574
Risk ratio 0.87 (0.54 to 1.41)
Risk difference 0% (−8 to 8) 0.982
Risk ratio 0.99 (0.36 to 2.7)
Risk difference −4% (−15 to 8) 0.518
Gestational Age Delivery defined as ≥ 90th customized birthweight centile [26].
stational age and gender. Weight adjustment for women with BMI ≥ 30 Kg/m2
Kg/m2.
ary outcomes are n (%), with Risk Difference and risk ratio.
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PA appeared too great to overcome, possibly reflecting
increased physical discomfort with gestation, as indi-
cated by the EQ-5D questionnaire.
The relationship between mental health, diet and PA
in obese pregnancies warrants further investigation in
the RCT in view of the high prevalence of depressive
symptoms (EPDS score > 12). Another report has also
found no effect of a complex behavioural intervention in
obese women on these symptoms [60].
In terms of context, the process evaluation recruited
women in urban hospitals serving regions with areas of
high socio-economic deprivation. Obesity rates are
higher amongst women with lower socio-economic sta-
tus, fewer qualifications [61] and amongst particular eth-
nic groups, particularly black African and black
Caribbean [62]. It was important therefore not only to
explore if recruitment was feasible but also whether the
intervention was acceptable to the women recruited.
Prominent media coverage about obesity raised the pos-
sibility that women in the control group might pro-
actively address diet and physical activity, and some
interview data supported this, but the evaluation sug-
gested that awareness through the media alone was not
adequate to achieve sufficient behavioural change.
In relation to reach, just over one third of eligible
women agreed to participate. Similarly low recruitment
rates are consistent with other intervention studies, par-
ticularly in populations with lower uptake of health care.
In one previous relevant study of lifestyle advice in non-
obese pregnant women, recruitment was slower than
expected and low attendance at group exercise sessions
and participant concern about burdensome data collec-
tion contributed to dropout [63]. However, perceived ad-
vantages to participation such as extra clinical tests and
continuity of care from research midwives supported
study uptake and continuation. Given the continued rise
in obesity in the adult population in England [61], ap-
proximately 1:5 pregnant women would be eligible for
inclusion. Recruitment of the numbers needed to be
approached (4100) for the full trial is therefore unlikely
to be affected by a shortage of eligible women. Overall,
the wide social and ethnic diversity amongst participants
was similar in participants and those who declined, indi-
cating that the intervention would be unlikely to in-
crease health inequalities by attracting more educated
and higher income participants [64]. Importantly, al-
though obese pregnant women, once recruited, were
generally willing to attend group sessions, practicalities
often interfered with regular attendance, thereby influen-
cing dose. However, the sessions did not appeal to all
women. Some appreciated finding common issues with
other group members, others preferred one to one con-
tact. Evidence for health improvement interventions ingroup settings is varied [65] and this study adds to the
recognition that a ‘one size fits all’ approach may not be
effective [64], and that flexibility is key to retention.
Fidelity was good with consistently high level provision
of SMART goals by HTs, which were viewed as a positive
achievement, particularly since poor adherence to goal
setting has been associated with moderate attendance
amongst pregnant women [66]. The high acceptability of
the participant handbook and pedometer re-enforced the
theoretical approach [16], and women also responded
well to motivational techniques, but physical issues
presented barriers to PA. The information provided was
valued, including increasing awareness of safe PA in
pregnancy, and seen to have important educational bene-
fit. Several components of the intervention therefore
appeared beneficial and were well received by women.
The intervention is relatively intensive and presents costs
for providers, and whilst a full assessment of cost and
benefit was not conducted in this pilot, steps taken dur-
ing the pre-clinical development phase (using HTs rather
than clinicians to deliver the intervention, adopting local
group-based approach) helped keep the overall costs of
the intervention low, recognising that if beneficial, it
should also be affordable to health providers and to
women. There was also suggestion that the intervention
may extend to peers and family, and some women as-
pired towards better fitness following birth. This study
has reinforced earlier reports suggesting that rapport be-
tween study staff and participants, interviews requiring
short time commitment, and participants' perception of
the study as informative are all important recruitment
and retention factors [67]. Formal evaluation of the rea-
sons for the high refusal rate was not permissible due to
ethical constraints, but the time commitment was fre-
quently commented upon by the recruitment staff, as
well as lack of appreciation of the health consequences of
obesity in pregnancy.
In summary, this study has emphasised the value of a
pilot trial to assess anticipated behaviour change. Al-
though seldom attempted by others, we have also
highlighted the importance of process evaluation in a
complex intervention of diet and physical activity for
pregnant women. The pilot trial demonstrated reduc-
tions in glycaemic load and in the proportion of energy
derived from saturated fat are achievable in obese preg-
nant women without GDM. The process evaluation
identified that dietary advice and education were well re-
ceived, and confirmed that PA change is more problem-
atic to achieve, although it remains important to
consistently measure and support PA using technologies
acceptable to women. The process evaluation also
helped explain issues arising in relation to uptake, dose,
fidelity and retention which informed the feasibility of
the full trial.
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to improve compliance and fidelity have now been
implemented in the protocol for the main trial. As well
as process evaluation, HT feedback highlighted potential
barriers to fidelity of the intervention and informed
protocol modifications for the RCT. Flexibility has been
increased regarding the timing and delivery of the ses-
sions, and goal setting can be undertaken by telephone
or email. It is recommended that women should receive
at least 5/8 sessions. The two extra visits required for
objective assessment of PA and accurate evaluation of
diet have been omitted in all but two sites (as planned)
and dietary assessment reduced to a validated FFQ. The
RPAQ includes domestic and childcare activities, consid-
ered appropriate for pregnant women [68], but following
feedback has been replaced by the shorter and more
relevant IPAQ [69]. Maintenance of dietary and PA be-
haviour change in the participant and her family is being
formally evaluated at 6 months and 3 years postpartum.
To minimise loss to follow-up and attendance at these
appointments, strategies which have been put in place
include regular newsletters and sending greetings cards
on special occasions such as the child’s birthday.Conclusions
Assumptions should not be made that interventions in
obese pregnant women necessarily change behaviour.
We recommend that a pilot trial such as that described
here, which has demonstrated evidence for anticipated
change in behaviour, is a necessary prelude to any RCT
of a complex intervention of diet and physical activity
designed to improve pregnancy outcome in obese
women. Without prior evidence for change in behaviour
in the anticipated direction, pursuit of a large and costly
trial would be futile. Similarly, we have demonstrated
the value of early process evaluation, which can lead to
important refinements in protocol to improve feasibility
and compliance in the definitive trial.Additional file
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